3
Participants
Start Date
August 17, 2021
Primary Completion Date
November 17, 2021
Study Completion Date
November 17, 2021
Sodium Zirconium Cyclosilicate (SZC)
Participants in the active arm will receive SZC dosed as per the local label to control hyperkalaemia and maintain normokalaemia.
Enhanced dietary advice
Participants will receive enhanced dietary advice in addition to taking SZC. This will include advice from dietitians to consume fruit and vegetables. Participants will be encouraged to consume up to 70 mmol K+ per day.
Standard dietary advice including K+ restriction.
Participants randomised to the SoC arm of the Diet Comparison Phase will receive standard dietary advice including K+ restriction.
Research Site, West Palm Beach
Lead Sponsor
AstraZeneca
INDUSTRY